134 related articles for article (PubMed ID: 34584697)
1. Postmenopausal virilization secondary to a large ovarian cystadenoma with stromal hyperthecosis.
Nizam W; Shah AA; Cornwell EE; Naab T; Williams M
Clin Case Rep; 2021 Sep; 9(9):e04774. PubMed ID: 34584697
[TBL] [Abstract][Full Text] [Related]
2. Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis.
Goldman JM; Kapadia LJ
Postgrad Med J; 1991 Mar; 67(785):304-6. PubMed ID: 2062784
[TBL] [Abstract][Full Text] [Related]
3. Mucinous cystadenoma of the ovary with functioning stroma and virilization in pregnancy: a case report and review of the literature.
Antoniou N; Varras M; Akrivis Ch; Demou A; Bellou A; Stefanaki S
Clin Exp Obstet Gynecol; 2003; 30(4):248-52. PubMed ID: 14664425
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels.
Shah S; Torres C; Gharaibeh N
Case Rep Endocrinol; 2022; 2022():9998807. PubMed ID: 35087692
[TBL] [Abstract][Full Text] [Related]
5. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
[TBL] [Abstract][Full Text] [Related]
6. Benign mucinous cystadenoma with stromal luteinization responsible for maternal virilization and fetal intrauterine growth restriction.
Bolat F; Parlakgumus A; Canpolat T; Tuncer I
J Obstet Gynaecol Res; 2011 Jul; 37(7):893-6. PubMed ID: 21450020
[TBL] [Abstract][Full Text] [Related]
7. [Clinical, hormonal and histological features in ovarian stromal hyperthecosis].
Abuladze MV; Sharabidze NG
Georgian Med News; 2006 Oct; (139):50-3. PubMed ID: 17077467
[TBL] [Abstract][Full Text] [Related]
8. Virilization and Enlarged Ovaries in a Postmenopausal Woman.
Guerrero J; Marcus JZ; Heller DS
Int J Surg Pathol; 2017 Sep; 25(6):507-508. PubMed ID: 28585475
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cystadenoma with stromal cell hyperplasia and postmenopausal virilization: a case report.
Caron P; Gorguet B; Bennet A; Cabot A; Louvet JP
Eur J Obstet Gynecol Reprod Biol; 1988 Aug; 28(4):341-5. PubMed ID: 3169360
[TBL] [Abstract][Full Text] [Related]
10. A rare ovarian hilus cell tumour accompanying bilateral serous cystadenomas: report of a case.
Malakzai HA; Abdul-Ghafar J; Ibrahimkhil AS; Haidary AM
J Ovarian Res; 2021 Jun; 14(1):81. PubMed ID: 34154625
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal virilization due to ovarian stromal hyperthecosis.
Braithwaite SS; Erkman-Balis B; Avila TD
J Clin Endocrinol Metab; 1978 Feb; 46(2):295-300. PubMed ID: 220276
[TBL] [Abstract][Full Text] [Related]
12. Rare case of testosterone producing serous cystadenoma.
Khalid A; Kotha M; Munir AA
Oxf Med Case Reports; 2022 Aug; 2022(8):omac087. PubMed ID: 35991491
[TBL] [Abstract][Full Text] [Related]
13. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
14. Hyperandrogenism in a postmenopausal woman.
García E; García-Hierro V; De La Maza L; Alvarez P; Santos E; Pi J; Castillo L; Ruiz E
Endocrinol Nutr; 2008 Oct; 55(8):376-8. PubMed ID: 22975603
[TBL] [Abstract][Full Text] [Related]
15. A 27-kg Giant Ovarian Mucinous Cystadenoma in a 72-Year-Old Postmenopausal Patient: A Case Report.
Akhras LN; Akhras LN; Faroog S; AlSebay L
Am J Case Rep; 2019 Nov; 20():1601-1606. PubMed ID: 31672957
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-producing ovarian mucinous cystadenomas in postmenopausal women.
Honda K; Ishiko O; Wakasa K; Kawabata S; Nishimura S; Ogita S
Oncol Rep; 2000; 7(4):803-8. PubMed ID: 10854548
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Stromal Hyperplasia: A Rare Cause of Postmenopausal Hyperandrogenism.
Lozoya Araque T; Monfort Ortiz IR; Martín González JE; Jiménez García A; Navarro Hidalgo I; Andrade Gamarra V; Parrell Soler C; Gil Raga F
J Menopausal Med; 2020 Apr; 26(1):39-43. PubMed ID: 32307950
[TBL] [Abstract][Full Text] [Related]
18. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
[TBL] [Abstract][Full Text] [Related]
19. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
Czyzyk A; Latacz J; Filipowicz D; Podfigurna A; Moszynski R; Jasinski P; Sajdak S; Gaca M; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2017 Nov; 33(11):836-839. PubMed ID: 28604129
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
